Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
Biocon Biologics Inpremzia gets backing from EMA expert panel Ruchika Sharma2 April 2022 12:43 PM ISTInpremzia is a pre-mixed ready-to-use insulin for IV infusion for patients in hospital and other acute care settings.
No shortage of essential drugs, other medical products in Kashmir: DFCO Medical Dialogues Bureau4 Sept 2019 9:15 AM ISTThe officials said that major companies operating in the valley are providing regular supplies of almost all categories of drugs including...
Type 1 diabetes cure comes closer to reality savita thakur thakur1 Feb 2016 11:06 AM ISTWashington: A team of scientists has been able to halt diabetic condition for six months with the help of insulin-producing cells, bringing the cure...
Insulin producing pancreatic cells successfully created in lab savita thakur thakur11 Jan 2016 11:29 AM ISTWashington: Fully functional pancreatic cells have been cultured by scientists from human skin cells, potentially meaning the end of daily insulin...
US scientists create insulin-producing pancreatic cells from human skin cells savita thakur thakur8 Jan 2016 12:13 PM ISTNew York: Scientists at a US university have successfully converted human skin cells into fully-functional pancreatic cells.The new cells produced...
Biocon targets emerging, developed markets with biosimilars Meghna A Singhania23 Oct 2015 8:38 AM ISTNEW DELHI: Biopharmaceuticals firm Biocon is looking to tap opportunities in biosimilars targeting diseases such as diabetes and cancer among others,...
